207 related articles for article (PubMed ID: 36651019)
1. Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series.
Lee JW; Yu DA; Cho S; Youn SW; Kwon O
J Dermatol; 2023 Jun; 50(6):814-819. PubMed ID: 36651019
[TBL] [Abstract][Full Text] [Related]
2. Alopecia universalis after drug reaction with eosinophilia and systemic symptoms (Dress).
Hollingsworth P; Paci K; Evans M; Miedema J; Morrell DS
Pediatr Dermatol; 2020 Sep; 37(5):947-949. PubMed ID: 32524672
[TBL] [Abstract][Full Text] [Related]
3. Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis.
Lian BS; Ha JH; Sultana R; Chan LCE; Choo KJL; Yeo YW; Lee HY
Am J Clin Dermatol; 2023 Jul; 24(4):637-647. PubMed ID: 37133714
[TBL] [Abstract][Full Text] [Related]
4. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cyclosporine and systemic corticosteroid for treating drug reaction with eosinophilia and systemic symptoms syndrome: A retrospective 20-year single-centre study in South Korea.
Kwon HJ; Yoon JH
Australas J Dermatol; 2023 Feb; 64(1):50-57. PubMed ID: 36695042
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid-induced drug reaction with eosinophilia and systematic symptoms successfully treated with a tumor necrosis factor alpha inhibitor.
Kim S; Joo EJ; Kim UJ; Kim JH; Kim B; Lee HJ; Chae SW; Kim HN; Cheong HS
Asian Pac J Allergy Immunol; 2022 Dec; 40(4):418-421. PubMed ID: 32170921
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine as an alternative immunosuppressant for steroid-resistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Tan K; Testro A
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36944441
[TBL] [Abstract][Full Text] [Related]
8. Drug reaction with eosinophilia and systemic symptoms: An emergency medicine focused review.
Gottlieb M; Figlewicz MR; Rabah W; Buddan D; Long B
Am J Emerg Med; 2022 Jun; 56():1-6. PubMed ID: 35338896
[TBL] [Abstract][Full Text] [Related]
9. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of QR678 and QR678 Neo
Shome D; Kapoor R; Doshi K; Patel G; Vadera S; Kumar V
J Cosmet Dermatol; 2022 Jan; 21(1):358-367. PubMed ID: 34825770
[TBL] [Abstract][Full Text] [Related]
11. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Cardones AR
Clin Dermatol; 2020; 38(6):702-711. PubMed ID: 33341203
[TBL] [Abstract][Full Text] [Related]
12. Alopecia in women.
Thiedke CC
Am Fam Physician; 2003 Mar; 67(5):1007-14. PubMed ID: 12643360
[TBL] [Abstract][Full Text] [Related]
13. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
[TBL] [Abstract][Full Text] [Related]
14. DRESS syndrome: a detailed insight.
Behera SK; Das S; Xavier AS; Selvarajan S
Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
[TBL] [Abstract][Full Text] [Related]
15. Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy.
Nylund M; Vuorinen T; Airas L
Mult Scler Relat Disord; 2020 Jul; 42():102058. PubMed ID: 32208345
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
Takehara A; Aoyama Y; Kurosawa M; Shirafuji Y; Umemura H; Kamiya K; Ushigome Y; Kano Y; Shiohara T; Iwatsuki K
Br J Dermatol; 2016 Nov; 175(5):944-952. PubMed ID: 27087170
[TBL] [Abstract][Full Text] [Related]
17. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come?
Martínez-Cabriales SA; Rodríguez-Bolaños F; Shear NH
Am J Clin Dermatol; 2019 Apr; 20(2):217-236. PubMed ID: 30652265
[TBL] [Abstract][Full Text] [Related]
18. Paediatric case series of drug reaction with eosinophilia and systemic symptoms (DRESS): 12-year experience at a single referral centre in Hong Kong and the first reported use of infliximab.
Chua GT; Rosa Duque JS; Chong PCY; Lee PPW; Lau YL; Ho MHK
Eur Ann Allergy Clin Immunol; 2018 Nov; 50(6):273-276. PubMed ID: 29384118
[TBL] [Abstract][Full Text] [Related]
19. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
Feaster B; Onamusi T; Cooley JE; McMichael AJ
Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
[TBL] [Abstract][Full Text] [Related]
20. How to identify DRESS, drug reaction with eosinophilia and systemic symptoms?
Sarajärvi P; Kubin M; Tasanen K; Huilaja L
Duodecim; 2017; 133(1):43-51. PubMed ID: 29199808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
